Try GOLD - Free
HC bars Sun Pharma's obesity drug in India
Mint Ahmedabad
|December 11, 2025
Pharma giant can't sell weight-loss drug in India till Novo’s patent expires
Semaglutide is the active ingredient in Novo Nordisk's Ozempic, Wegovy and Rybelsus - a class of drugs called glucagon-like peptide-1 agonists.
(MINT)
The Delhi High Court on Wednesday restrained Sun Pharmaceutical Industries Ltd from selling its generic version of the weight-loss drug semaglutide drug in India until Danish innovator Novo Nordisk’s patent expires in March 2026.
This story is from the December 11, 2025 edition of Mint Ahmedabad.
Subscribe to Magzter GOLD to access thousands of curated premium stories, and 10,000+ magazines and newspapers.
Already a subscriber? Sign In
MORE STORIES FROM Mint Ahmedabad
Mint Ahmedabad
'If you're on trend, you are in trouble'
Patou creative head Guillaume Henry discusses the essence of couture and why simple is best
4 mins
December 13, 2025
Mint Ahmedabad
GST cuts, easing inflation drive rural demand revival
India’s rural economy expanded and recovered strongly in late 2025, with consumption, incomes and investment improving after a key tax reform and as inflation eased, a survey showed.
2 mins
December 13, 2025
Mint Ahmedabad
Chair man, of the bored
STREAM OF STORIES
3 mins
December 13, 2025
Mint Ahmedabad
Anju Dodiya creates disquieting worlds
Artist Anju Dodiya discusses the ideas, influences and inspiration behind her new solo show, 'The Geometry of Ash'
5 mins
December 13, 2025
Mint Ahmedabad
Bar hopping with Lounge
\"The things that make a cocktail really great are often very simple details—the frozen glass, the lemon twist—that transform two fingers of alcohol into an ice-glazed elixir,\" writes Alice Lascelles in her excellent guide to making cocktails at home, The Cocktail Edit.
1 mins
December 13, 2025
Mint Ahmedabad
New Delhi and France revise 1992 tax treaty
India and France have struck a deal to revise their 1992 treaty which will halve the tax on dividends paid by Indian units to French parents, potentially saving millions for companies with major operations in the South Asian nation, documents show.
1 min
December 13, 2025
Mint Ahmedabad
Ozempic debuts with a ₹2,200-a-week price tag
for chronic weight management, Novo Nordisk is positioning Ozempic as a treatment of type 2 diabetes with weight loss benefits, competing with Eli Lily’s Mounjaro that was launched in India in March.
1 mins
December 13, 2025
Mint Ahmedabad
How 'puri-aloo' and 'chaat' unite Lucknow
Whenever my friends want to eat puri-aloo, they invite themselves over to my home.
5 mins
December 13, 2025
Mint Ahmedabad
Novo Nordisk debuts Ozempic at ₹2,200 a week
Danish drugmaker Novo Nordisk on Friday launched its blockbuster diabetes drug Ozempic in India, with a starting price of ₹2,200 per week.
1 mins
December 13, 2025
Mint Ahmedabad
Govt’s insurance reform allows 100% FDI, composite licences
The government has paved the way for 100% foreign direct investment in the insurance sector, composite licences and easier capital requirements, among others sweeping reforms, as the Union cabinet cleared the enabling legislation, said two officials aware of the matter.
1 mins
December 13, 2025
Listen
Translate
Change font size